Skip to content

Public FDA record

Z-2323-2025: HemosIL LMW Heparin Controls; Part Number: 0020300200;

Recall record Z-2323-2025 for Instrumentation Laboratory. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2323-2025
Company in FDA record
Instrumentation Laboratory
FDA classification date
Aug 13, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.

Source facts

Action
On February 3, 2025, URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. Requested Customer Actions Please take the following actions: " Follow the instructions in the original Urgent Medical Device Correction letter to update the ACL TOP test parameters with the corrected value assignments for HemosIL Heparin Calibrators (Part No. 0020300600). " For HemosIL UF Heparin Controls (Part No. 0020300300), continue to use the current target values and acceptance ranges as labeled. " For HemosIL LMW Heparin Controls (Part No. 0020300200), use the reassigned target values and acceptance ranges for the Low and High Controls as provided in the table above. " Note: if the 2D Barcode is scanned, customers need to manually override the uploaded values with those provided in this letter. " Follow the instructions below to update the Quality Control Material Definitions with the updated values (same instructions for all Instrument models): " Select Setup from the menu bar and then select Material List from the dropdown menu. " From Material List , double click on the Material Name LMW Hep Low Control and LMW Hep High Control (performed separately) to open Material Definition . " From Material Definition LMW Hep Low Control or LMW Hep High Control , click on Assigned Values icon (picture of bullseye) under the header. An editable table titled Assigned Values for IL Material Definition Quality Control LMW Hep Low Control or LMW Hep High Control will appear with the Anti-Xa Test Code, Active Lot, and Alternative Lot (if applicable). " In the Assigned Values table, select the Active and/or Alternative lot, and change the target values for LMW Hep Low Control and LMW Hep High Control to the reassigned values provided in the table. " After entering the reassigned values for LMW Hep Low Control and LMW Hep High Control , click on OK to save the changes. " Run quality controls per labeled instructions for use. New acceptance ranges for HemosIL L
Initiated
2025-02-03
Root cause
Process control
Distribution
Worldwide - US Nationwide and the countries of Algeria, Andorra, Argentina, Australia, Austria, Belarus, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Finland, Germany, Gibraltar, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Kyrgyzstan, Lebanon, Lithuania, Macao, Malaysia, Mexico, Panama, Paraguay, Peru, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, United Kingdom, Uruguay, Vietnam.
Recall number
Z-2323-2025
Recall status
Open, Classified
CDRH record ID
214519
FDA classified
2025-08-13
Recall event number
97093

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗